Dr Paul Fairchild, The Oxford Stem Cell Institute
Abstract: Few scientific advances have been so widely acclaimed and yet so controversial as stem cell biology. The first derivation of human embryonic stem (ES) cells in 1998, marked a turning point in biomedical science by unlocking the promise of regenerative medicine. And yet, as we approach the 10th anniversary of this seminal achievement, ES cells have yet to make any impact on the clinic. This seminar will explore not only the potential that stem cells offer for the future, but the challenges that remain to be overcome and the role that Oxford continues to play in seeking innovative ways to resolve them.